Search

Showing 12,861-12,880 of 13,859 items.

Evidence for Countercyclical Risk Aversion: An Experiment with Financial Professionals

By Alain Cohn, Jan Engelmann, Ernst Fehr, and Michel André Maréchal

American Economic Review, February 2015

Countercyclical risk aversion can explain major puzzles such as the high volatility of asset prices. Evidence for its existence is, however, scarce because of the host of factors that simultaneously change during financial cycles. We circumvent these p...

The Superiority of Economists

By Marion Fourcade, Etienne Ollion, and Yann Algan

Journal of Economic Perspectives, Winter 2015

In this essay, we analyze the dominant position of economics within the network of the social sciences in the United States. We begin by documenting the relative insularity of economics, using bibliometric data. Next we analyze the tight management of t...

The Case for Paying College Athletes

By Allen R. Sanderson and John J. Siegfried

Journal of Economic Perspectives, Winter 2015

Big-time commercialized intercollegiate athletics has attracted considerable attention in recent years. Popularity of this uniquely American activity, measured by attendance, television ratings, or team revenues, has never been higher. At the same time,...

Pricing in the Market for Anticancer Drugs

By David H. Howard, Peter B. Bach, Ernst R. Berndt, and Rena M. Conti

Journal of Economic Perspectives, Winter 2015

In 2011, Bristol-Myers Squibb set the price of its newly approved melanoma drug ipilimumab— brand name Yervoy—at $120,000 for a course of therapy. The drug was associated with an incremental increase in life expectancy of four months. Drugs ...